META-ANALYSIS OF NEXT GENERATION SEQUENCING PANEL USING CIRCULATING TUMOR DNA IN PATIENT WITH ADVANCED NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Ho, R. [1 ]
Sebastiao, M. [2 ]
Carvalho, J. [2 ]
Bramley, S. [3 ]
Schneider, C. [4 ]
Nussbaum, M. [2 ]
机构：
[1] Roche Diagnost Brazil, Sao Paulo, SP, Brazil
[2] Roche Diagnost Brazil, Sao Paulo, Brazil
[3] Roche Sequencing Solut, Burgess Hill, W Sussex, England
[4] Roche Sequencing Solut, Pleasanton, CA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMU93
引用
收藏
页码：S250 / S250
页数：1
相关论文
共 50 条
  • [1] Detection of Actionable Mutation Status in Advanced Non-Small Cell Lung Cancer by Next-Generation Sequencing of Circulating Tumor DNA
    Yang, Y.
    Song, X.
    Guo, W.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S715 - S715
  • [2] COST-EFFECTIVENESS ANALYSIS OF NEXT GENERATION SEQUENCING PANEL OF CIRCULATING TUMOR DNA IN THE DIAGNOSIS OF PATIENT WITH METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER IN BRAZIL
    Ho, R.
    Sebastiao, M. M.
    D'Innocenzo, M.
    Nussbaum, M.
    [J]. VALUE IN HEALTH, 2019, 22 : S333 - S333
  • [3] Next generation sequencing based targeted panel analysis in advanced non-small cell lung cancer (NSCLC)
    Erdamar, S.
    Barut, P.
    Eksioglu, A.
    Yakicier, C.
    Olcaysoy, B.
    Tokat, F.
    Ince, U.
    [J]. VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S135 - S135
  • [4] Detection of EGFR alterations in circulating tumor DNA of non-small cell lung cancer by digital PCR and Next Generation Sequencing
    Malpeli, G.
    Simbolo, M.
    Pilotto, S.
    Lawlor, R. T.
    Peretti, U.
    Bonizzato, G.
    Kinspergher, S.
    Ferrara, R.
    Cantu, C.
    Caccese, M.
    Tortora, G.
    Bria, E.
    Scarpa, A.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 79 - 79
  • [5] Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
    Hou, Helei
    Yang, Xiaonan
    Zhang, Jinping
    Zhang, Zhe
    Xu, Xiaomei
    Zhang, Xiaoping
    Zhang, Chuantao
    Liu, Dong
    Yan, Weihua
    Zhou, Na
    Zhu, Hongmei
    Qian, Zhaoyang
    Li, Zhuokun
    Zhang, Xiaochun
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [6] Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay
    Helei Hou
    Xiaonan Yang
    Jinping Zhang
    Zhe Zhang
    Xiaomei Xu
    Xiaoping Zhang
    Chuantao Zhang
    Dong Liu
    Weihua Yan
    Na Zhou
    Hongmei Zhu
    Zhaoyang Qian
    Zhuokun Li
    Xiaochun Zhang
    [J]. Scientific Reports, 7
  • [7] Circulating tumor DNA testing in advanced non-small cell lung cancer
    Moding, Everett J.
    Diehn, Maximilian
    Wakelee, Heather A.
    [J]. LUNG CANCER, 2018, 119 : 42 - 47
  • [8] Circulating tumor DNA evaluated by Next-Generation Sequencing is predictive of tumor response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancer
    Leprieur, Etienne Giroux
    Herbretau, Guillaume
    Dumenil, Coraline
    Julie, Catherine
    Giraud, Violaine
    Labrune, Sylvie
    Dumoulin, Jennifer
    Tisserand, Julie
    Emile, Jean-Francois
    Blons, Helene
    Chinet, Thierry
    [J]. ONCOIMMUNOLOGY, 2018, 7 (05):
  • [9] Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
    Qiu, Mantang
    Wang, Jie
    Xu, Youtao
    Ding, Xiangxiang
    Li, Ming
    Jiang, Feng
    Xu, Lin
    Yin, Rong
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 206 - 212
  • [10] Clinical applications of a next-generation sequencing panel in non-small cell lung cancer
    Rijavec, E.
    Genova, C.
    Barletta, G.
    Biello, F.
    Maggioni, C.
    Dal Bello, M. G.
    Truini, A.
    Coco, S.
    Vanni, I.
    Alama, A.
    Grossi, F.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 86 - 87
12345